Mannan Composition of the Hyphal Form of Two Relatively Avirulent Mutants of Candida Albicans

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1990 Jul 1

PMID 2194957

Citations 5

Authors

A Saxena

R L Cihlar

Affiliations

Soon will be listed here.

Abstract

We have previously reported the characteristics of mannans isolated from the yeast forms of two relatively avirulent Candida albicans strains, designated 4918-2 and 4918-10. Investigations have been expanded to include an analysis of mannans from the hyphal form of these strains as well as from the hyphal form of the parental strain, 4918. After extraction, mannans were further purified by high-pressure liquid chromatography on a Bio-gel TSK DEAE-5-PW column. Subsequent to either mild acid hydrolysis, alkali hydrolysis, or acetylation followed by acetolysis, the resulting products were fractionated by high-pressure liquid chromatography on an Aminex HPX-42A column. The results of acid hydrolysis showed only minor quantitative differences in the products released from each strain, with mannose constituting the vast majority of product liberated. The profiles of mannooligosaccharides obtained from either alkali hydrolysis or acetolysis for strain 4918-2 showed distinct quantitative differences compared with profiles of the other two strains. Finally, a general characteristic noted is a decrease in the average chain length of mannooligosaccharides in hyphal mannans compared with the yeast counterpart.

Citing Articles

Abnormal proliferation of gut mycobiota contributes to the aggravation of Type 2 diabetes.

Bao L, Zhang Y, Zhang G, Jiang D, Yan D Commun Biol. 2023; 6(1):226.

PMID: 36854740 PMC: 9974954. DOI: 10.1038/s42003-023-04591-x.

Characterization of mutant strains of Candida albicans deficient in expression of a surface determinant.

Chaffin W, Collins B, Marx J, Cole G, Morrow Jr K Infect Immun. 1993; 61(8):3449-58.

PMID: 8335375 PMC: 281022. DOI: 10.1128/iai.61.8.3449-3458.1993.

Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components.

Castro M, Ralston N, Morgenthaler T, Rohrbach M, Limper A Infect Immun. 1994; 62(8):3138-45.

PMID: 8039882 PMC: 302938. DOI: 10.1128/iai.62.8.3138-3145.1994.

Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Nelson R, Shibata N, Podzorski R, Herron M Clin Microbiol Rev. 1991; 4(1):1-19.

PMID: 2004345 PMC: 358175. DOI: 10.1128/CMR.4.1.1.

Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

Blasi E, Pitzurra L, Puliti M, Lanfrancone L, Bistoni F Infect Immun. 1992; 60(3):832-7.

PMID: 1541557 PMC: 257562. DOI: 10.1128/iai.60.3.832-837.1992.

References

KOCOUREK J, Ballou C . Method for fingerprinting yeast cell wall mannans. J Bacteriol. 1969; 100(3):1175-81. PMC: 250284. DOI: 10.1128/jb.100.3.1175-1181.1969. View

Saxena A, Hammer C, Cihlar R . Analysis of mannans of two relatively avirulent mutant strains of Candida albicans. Infect Immun. 1989; 57(2):413-9. PMC: 313112. DOI: 10.1128/iai.57.2.413-419.1989. View

Omura S . The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol Rev. 1976; 40(3):681-97. PMC: 413976. DOI: 10.1128/br.40.3.681-697.1976. View

Peterson G . A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977; 83(2):346-56. DOI: 10.1016/0003-2697(77)90043-4. View

Manning M, Mitchell T . Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicans in low-sulfate, synthetic medium. J Bacteriol. 1980; 142(2):714-9. PMC: 294057. DOI: 10.1128/jb.142.2.714-719.1980. View

Maisch P, Calderone R . Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro. Infect Immun. 1981; 32(1):92-7. PMC: 350592. DOI: 10.1128/iai.32.1.92-97.1981. View

McCourtie J, Douglas L . Relationship between cell surface composition of Candida albicans and adherence to acrylic after growth on different carbon sources. Infect Immun. 1981; 32(3):1234-41. PMC: 351584. DOI: 10.1128/iai.32.3.1234-1241.1981. View

Hamada T, Nakajima T, Izaki K, Matsuda K . Comparison of the mannan structure from the cell-wall mutant Candida sp. M-7002 and its wild type. I. Characterization of the proteo-mannan from the mutant and the wild-type cells. Eur J Biochem. 1981; 119(2):365-71. DOI: 10.1111/j.1432-1033.1981.tb05617.x. View

Omura S . Cerulenin. Methods Enzymol. 1981; 72:520-32. View

10.

Samaranayake L, MacFarlane T . The adhesion of the yeast Candida albicans to epithelial cells of human origin in vitro. Arch Oral Biol. 1981; 26(10):815-20. DOI: 10.1016/0003-9969(81)90178-3. View

11.

Suzuki M, Fukazawa Y . Immunochemical characterization of Candida albicans cell wall antigens: specific determinant of Candida albicans serotype A mannan. Microbiol Immunol. 1982; 26(5):387-402. DOI: 10.1111/j.1348-0421.1982.tb00189.x. View

12.

Lee J, King R . Characterization of Candida albicans adherence to human vaginal epithelial cells in vitro. Infect Immun. 1983; 41(3):1024-30. PMC: 264603. DOI: 10.1128/iai.41.3.1024-1030.1983. View

13.

McCourtie J, Douglas L . Relationship between cell surface composition, adherence, and virulence of Candida albicans. Infect Immun. 1984; 45(1):6-12. PMC: 263245. DOI: 10.1128/iai.45.1.6-12.1984. View

14.

Klotz S, Drutz D, Zajic J . Factors governing adherence of Candida species to plastic surfaces. Infect Immun. 1985; 50(1):97-101. PMC: 262141. DOI: 10.1128/iai.50.1.97-101.1985. View

15.

Calderone R, Cihlar R, Lee D, Hoberg K, Scheld W . Yeast adhesion in the pathogenesis of endocarditis due to Candida albicans: studies with adherence-negative mutants. J Infect Dis. 1985; 152(4):710-5. DOI: 10.1093/infdis/152.4.710. View

16.

Hoberg K, Cihlar R, Calderone R . Characterization of cerulenin-resistant mutants of Candida albicans. Infect Immun. 1986; 51(1):102-9. PMC: 261071. DOI: 10.1128/iai.51.1.102-109.1986. View

17.

Shibata N, Ichikawa T, Tojo M, Takahashi M, Ito N, Okubo Y . Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys. 1985; 243(2):338-48. DOI: 10.1016/0003-9861(85)90511-9. View

18.

Lehrer N, Segal E, Cihlar R, Calderone R . Pathogenesis of vaginal candidiasis: studies with a mutant which has reduced ability to adhere in vitro. J Med Vet Mycol. 1986; 24(2):127-31. DOI: 10.1080/02681218680000191. View

19.

Shibata N, Kobayashi H, Tojo M, Suzuki S . Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T. Arch Biochem Biophys. 1986; 251(2):697-708. DOI: 10.1016/0003-9861(86)90379-6. View

20.

Calderone R, Wadsworth E . Characterization of mannoproteins from a virulent Candida albicans strain and its derived, avirulent strain. Rev Infect Dis. 1988; 10 Suppl 2:S423-7. DOI: 10.1093/cid/10.supplement_2.s423. View